Nature Reviews Clinical Oncology

Nature Portfolio

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Nature Reviews Clinical Oncology is a journal published by Nature Portfolio in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Nature Portfolio
ISSN
1759-4774 · 1759-4782
Country
United Kingdom
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2009-01-01
  • PUBMED · 2010-12-07
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

3363

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

284

i10-index

1202

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
61%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Clinical oncology
Source type
journal
NLM unique ID (PubMed)
101500077
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • CAR-T cell therapy research
Show all subjects (50)
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Immunotherapy and Immune Responses
  • Multiple Myeloma Research and Treatments
  • Immunotherapy and Immune Responses
  • Multiple Myeloma Research and Treatments
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Economic and Financial Impacts of Cancer
  • Protein Degradation and Inhibitors
  • Economic and Financial Impacts of Cancer
  • Protein Degradation and Inhibitors
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: